Josephine A. Taverna, M.D., is a thoracic oncologist with expertise in lung cancer and drug development, dedicated to advancing translational research that bridges mechanistic discovery with clinical application is a lung cancer expert. Dr. Taverna is a researcher at the Mays Cancer Center at UT Health San Antonio, where she’s helping lead the charge to overcome one of cancer’s toughest challenges, tumors that stop responding to immunotherapy. Her team studies how to “retrain” the body’s immune system to fight lung cancer more effectively. In recent work, Dr. Taverna’s lab found that combining several targeted medicines could wake up immune cells that had stopped recognizing cancer, leading to much stronger anti-tumor activity in preclinical studies. Dr. Taverna trained at the University of Arizona and now, with funding from the V Foundation 2024 Translational grant, National Institutes of Health (NIH) and other organizations, she’s turning those discoveries into a new clinical trial for patients with advanced lung cancer, bringing lab science directly to those who need it most.
Mailing List
